Targeted DNA vaccines eliciting crossreactive anti-idiotypic antibody responses against human B cell malignancies in mice

BACKGROUND: Therapeutic idiotypic (Id) vaccination is an experimental treatment for selected B cell malignancies. A broader use of Id-based vaccination, however, is hampered by the complexity and costs due to the individualized production of protein vaccines. These limitations may be overcome by tar...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ruffini, Pier Adelchi, Os, Audun, Dolcetti, Riccardo, Tjønnfjord, Geir E, Munthe, Ludvig A, Bogen, Bjarne
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4119056/
https://ncbi.nlm.nih.gov/pubmed/25059102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1479-5876-12-207
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires